Critical Analysis of India-US  Interim Trade Agreement

Critical Analysis of India-US  Interim Trade Agreement

India and the United States have unveiled an Interim Trade Agreement that reshapes their economic relationship. This report critically evaluates the deal through sector-wise winners and losers, tariff-cut sensitivity data, and a negotiation leverage scorecard, explaining what the agreement truly means for India’s manufacturing future, exports, and strategic alignment.

New Delhi (ABC Live): India-US  Interim Trade Agreement: India–U.S. trade relations have long been shaped by managed friction, selective cooperation, and recurring disputes, rather than deep economic integration. Consequently, tariff battles, WTO litigation, and narrow sector bargains defined the landscape. As a result, a comprehensive bilateral trade structure never fully emerged.

Against this backdrop, the newly announced Interim Trade Agreement framework between the United States and India marks a clear break from the past. Importantly, ABC Live has earlier explained the emerging deal architecture:
👉 https://abclive.in/2026/02/03/india-us-trade-deal/

Instead of resembling a classical Free Trade Agreement, the framework adopts a different design. Likewise, it does not promise instant, across-the-board tariff removal. Rather, it creates a strategic industrial alignment structure, where trade concessions link directly to supply-chain security, national-security carve-outs, standards cooperation, and long-term technology partnership.

At its core, the framework raises a simple but powerful question:

Is India ready to trade some tariff control for a permanent place inside Western manufacturing and technology supply chains?

Accordingly, this report evaluates the Interim Agreement using three tools:

  1. Sector-wise Winners / Losers Matrix
  2. Tariff-Cut Sensitivity Analysis
  3. Negotiation Leverage Scorecard for the upcoming BTA phase

Taken together, these tools show that the Interim Agreement is high-reward but high-risk. Outcomes will depend on sequencing, reciprocity, and execution.

I. Sector-Wise Winners / Losers Matrix (India)

Sector Export Exposure to the U.S. Key Provision Short-Term Impact Medium-Term Impact Verdict
Generic pharmaceuticals Very high Conditional tariff removal; Section 232 outcomes Limited relief Large export growth Strong winner
Gems & diamonds High Identified for tariff removal Neutral Higher margins Strong winner
Aircraft parts & aerospace Medium Section 232 carve-outs Positive Supply-chain entry Winner
Auto components Medium Preferential TRQ Modest gain Stable growth Moderate winner
ICT hardware/electronics Medium NTBs removed by India Cost pressure Assembly + exports rise Winner
IT & digital services High Digital trade pathway Stable Growth Winner
Textiles & apparel Very high 18% U.S. reciprocal tariff Negative Possible upside Mixed
Leather & footwear Medium Same as textiles Negative Possible upside Mixed
Chemicals & plastics Medium Initial reciprocal tariff Negative Uncertain Mixed
Agriculture (U.S. imports) High sensitivity India tariff cuts Negative Structural pressure Loser
Medical devices (India market) High sensitivity NTB reforms Negative Margin squeeze Loser

Taken together, three patterns stand out. First, India’s export-competitive manufacturing sectors gain. Second, India’s protected domestic sectors face pressure. Third, gains concentrate in urban, capital-intensive industries, while pain falls on rural and healthcare segments. Therefore, the agreement creates clear distributional tension.

II. Tariff-Cut Sensitivity Analysis (India Exports to U.S.)

Assumption: Baseline export index = 100

U.S. Tariff Level Price Position Export Change Export Index
18% High disadvantage –8% 92
10% Moderate disadvantage +3% 103
5% Near parity +9% 109
0% Strong parity +15% 115

In practice, exports respond strongly only when tariffs fall below about 10%. By contrast, small cuts do little. Hence, deep cuts matter.

Accordingly, the Interim Agreement delivers real value only if it quickly moves toward low or zero tariffs for priority goods.

III. Negotiation Leverage Scorecard (BTA Phase)

Scale: 0–10 (higher = stronger leverage)

Issue Area India U.S. Advantage
Pharma & APIs 8.5 7.5 India
Rules of origin 7.5 7.5 Balanced
Standards recognition 7.0 7.0 Balanced
Textiles/apparel 6.5 6.5 Balanced
Critical minerals / China+1 7.5 6.5 India
Energy purchases 5.5 8.5 U.S.
Aircraft procurement 6.0 8.0 U.S.
Digital trade 6.5 8.5 U.S.
Medical devices 4.5 8.0 U.S.
Agriculture access 4.0 8.5 U.S.

In effect, India’s strongest chips lie in pharma and supply-chain resilience. Meanwhile, U.S. power is highest in energy, agriculture, medical devices, and digital trade. Therefore, India must trade carefully.

IV. Structural Strengths of the Interim Agreement

Notably, most winners fall in pharma, electronics, aerospace, and auto components. At the same time, these sectors match India’s manufacturing push. Therefore, the agreement supports domestic industrial policy.

More importantly, national-security carve-outs and trusted-partner status create lasting advantages. In comparison, small tariff changes matter less.

Simply put, when prices fall, Indian exports rise quickly. As a result, deep tariff cuts can produce rapid gains.

V. Structural Weaknesses and Risks

However, India moves first. Meanwhile, many U.S. benefits come later. Consequently, this creates execution risk.

Likewise, textiles employ millions. If tariff relief is delayed, market share could shift permanently. Therefore, this sector represents the most time-sensitive risk.

Similarly, farmers and medical-device makers will resist change. Unless safeguards exist, backlash is likely.

VI. Strategic Character of the Agreement

Taken together, this is not a simple trade deal. Rather, it is a geopolitical industrial alignment pact. As ABC Live earlier noted in its analysis of earlier U.S.–India trade negotiations:
👉 https://abclive.in/2025/07/02/us-india-trade-deal/

India is being invited into advanced-economy supply chains in exchange for market opening and rule alignment.

VII. Who Gains More?

In the short term, the United States gains more. Over the medium to long term, India gains—if tariff removals and pharma outcomes happen.

VIII. What Will Determine Success

  1. Early tariff removal on priority Indian exports
  2. Fast relief for textiles and apparel
  3. Positive pharma Section 232 outcomes
  4. TRQs and safeguards for agriculture
  5. Protection of public-health regulation space

Final Judgment

Ultimately, the Interim Trade Agreement must be judged by outcomes, not intent.

The Interim Trade Agreement is strategically bold but economically unfinished.

It offers India a path to become a manufacturing power within advanced supply chains. However:

This deal is a bet on India’s industrial future.
It is not yet a guarantee.

Source of India-US  Interim Agreement: PIB Statement

Team ABC's avatar
Team ABC
ADMINISTRATOR
PROFILE

Posts Carousel

Leave a Comment

You must be logged in to post a comment.

Latest Posts

Top Authors

Most Commented

Featured Videos

728 x 90

Discover more from ABC Live

Subscribe now to keep reading and get access to the full archive.

Continue reading